Home / Investor Relations / CEO Commentaries

CEO Commentaries

Scale Matters

Metastases are believed to originate from a rare type of tumor cells known as cancer stem cells. A combined tool for identifying and studying rare cells would provide cancer researchers with new information to better under­stand the nature of cancer stem cells, and hopefully allow them to develop treatments against these rare and deadly cells.
Read More

The Label-free Promise

To transform an invention to a product that can be purchased by any scientist is the often unappreciated but crucial role of commercializing enterprises. This was the underlying theme of my presentation at SPIE 2018, “The evolution of Phase Holographic Imaging from a research idea to publicly traded company”.
Read More

Life is a mess

In our daily lives, we all know how important it is to plan ahead to avoid a future mess. Ironically, we ourselves are such a future mess.
Read More

Fighting cancer with nanoparticles

Using HoloMonitor, scientists at Northeastern University have shown that paclitaxel-resistant ovarian cancer cells stopped multiplying by cell division when treated with nanoparticles. Ovarian cancer causes more deaths than any other cancer of the female reproductive system.
Read More

No Blood, No Tumor

Scientists at Boston Children’s Hospital have used HoloMonitor to study living bone cancer cells. By studying their dynamics, they have successfully for the first time distinguished aggressive bone cancer cells that promote blood vessel formation from the harmless counterparts that do not promote blood vessel formation.
Read More

Big Data, Fewer Cells

Scientists at Holographic Imaging Cytometry Program of Excellence at Northeastern University have developed a method to compare time series data of drug treated cells with untreated cells.
Read More